Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue ▾	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
JNJ	Johnson & Johnson Manufacturing · Year ended 2025-12-28 · USD	$94.19B	$26.80B	28.5%	32.9%	6.0%	$11.03
LLY	Eli Lilly & Co Manufacturing · Year ended 2025-12-31 · USD	$65.18B	$20.64B	31.7%	77.8%	44.7%	$22.95
MRK	Merck & Co., Inc. Manufacturing · Year ended 2025-12-31 · USD	$65.01B	$18.25B	28.1%	34.7%	1.3%	$7.28
PFE	Pfizer Inc Manufacturing · Year ended 2025-12-31 · USD	$62.58B	$7.77B	12.4%	9.0%	-1.6%	$1.36
ABBV	AbbVie Inc. Manufacturing · Year ended 2025-12-31 · USD	$61.16B	$4.23B	6.9%	n/a	8.6%	$2.36
BMY	Bristol Myers Squibb Co Manufacturing · Year ended 2025-12-31 · USD	$48.19B	$7.05B	14.6%	38.2%	-0.2%	$3.46
ABT	Abbott Laboratories Manufacturing · Year ended 2025-12-31 · USD	$44.33B	$6.52B	14.7%	12.5%	5.7%	$3.72
TEVA	Teva Pharmaceutical Industries Ltd Manufacturing · Year ended 2025-12-31 · USD	$17.26B	$1.41B	8.2%	17.8%	4.3%	$1.21
REGN	Regeneron Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$14.34B	$4.50B	31.4%	14.4%	1.0%	$41.48
VTRS	Viatris Inc Manufacturing · Year ended 2025-12-31 · USD	$14.30B	-$3.51B	-24.6%	-23.9%	-3.0%	-$3.00
VRTX	Vertex Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$12.00B	$3.95B	32.9%	21.2%	8.9%	$15.32
BHC	Bausch Health Companies Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.27B	$120.00M	1.2%	31.8%	6.7%	$0.42
ZTS	Zoetis Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.47B	$2.67B	28.2%	80.2%	2.3%	$6.02
OGN	Organon & Co. Manufacturing · Year ended 2025-12-31 · USD	$6.22B	$187.00M	3.0%	24.9%	-2.9%	$0.72
ONC	BeOne Medicines Ltd. Manufacturing · Year ended 2025-12-31 · USD	$5.34B	$286.93M	5.4%	6.6%	40.2%	$0.19
ELAN	Elanco Animal Health Inc Manufacturing · Year ended 2025-12-31 · USD	$4.71B	-$232.00M	-4.9%	-3.5%	6.2%	-$0.47
JAZZ	Jazz Pharmaceuticals plc Manufacturing · Year ended 2025-12-31 · USD	$4.27B	-$356.15M	-8.3%	-8.2%	4.9%	-$5.84
PRGO	Perrigo Co PLC Manufacturing · Year ended 2025-12-31 · USD	$4.25B	-$1.43B	-33.5%	-48.6%	-2.8%	-$10.29
ALNY	Alnylam Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.71B	$313.75M	8.4%	39.8%	65.2%	$2.33
BMRN	BioMarin Pharmaceutical Inc Manufacturing · Year ended 2025-12-31 · USD	$3.22B	$348.90M	10.8%	5.7%	12.9%	$1.80
UTHR	United Therapeutics Corp Manufacturing · Year ended 2025-12-31 · USD	$3.18B	$1.33B	41.9%	18.8%	10.6%	$27.86
AMRX	Amneal Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.02B	$72.06M	2.4%	n/a	8.0%	$0.22
RPRX	Royalty Pharma plc Manufacturing · Year ended 2025-12-31 · USD	$2.38B	$770.95M	32.4%	7.9%	5.1%	$1.78
SRPT	Sarepta Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.20B	-$713.41M	-32.5%	-62.5%	15.6%	-$7.13
PTCT	PTC Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.73B	$682.64M	39.4%	n/a	114.5%	$7.78

Rows per page: 2550 100